Incidence of CVD Decreases More in High-Risk Patients with Lower LDL-C during Pravastatin Treatment

The PIV APPROACH-J study of pravastatin in high-risk patients without a history of cardiovascular disease (CVD) revealed that the incidence of CVD decreased more in patients with lower LDL cholesterol (LDL-C) levels during treatment with pravastatin. Also, the study demonstrated...read more